Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
| $6.4M | ﹤0.01% |
+68,600
| New | +$5.47M |
|
|
COOP
2802
DELISTED
Mr. Cooper
COOP
| $6.39M | ﹤0.01% |
206,098
-575,732
| -74% | -$14.7M |
|
2803
Installed Building Products
IBP
$6.49B
| $6.38M | ﹤0.01% |
62,568
-37,650
| -38% | -$3.85M |
|
2804
PUT
Sempra
SRE
$54.8B
| $6.37M | ﹤0.01% |
100,000
| – | – |
|
2805
James River Group Holdings
JRVR
$217M
| $6.35M | ﹤0.01% |
129,107
+49,203
| +62% | +$2.38M |
|
2806
Pan American Silver
PAAS
$21.6B
| $6.34M | ﹤0.01% |
183,663
-2,334
| -1% | -$75.3K |
|
2807
PUT
Philip Morris
PM
$295B
| $6.33M | ﹤0.01% |
76,400
-26,400
| -26% | -$2.06M |
|
2808
Arcutis Biotherapeutics
ARQT
$3.18B
| $6.32M | ﹤0.01% |
224,765
+45,389
| +25% | +$1.11M |
|
2809
Pediatrix Medical
MD
$2.2B
| $6.32M | ﹤0.01% |
257,615
-159,904
| -38% | -$3M |
|
2810
PUT
Sony
SONY
$138B
| $6.32M | ﹤0.01% |
312,500
| – | – |
|
2811
Conduent
CNDT
$264M
| $6.3M | ﹤0.01% |
1,313,597
-211,171
| -14% | -$882K |
|
2812
iShares Currency Hedged MSCI Japan ETF
HEWJ
$744M
| $6.3M | ﹤0.01% |
175,759
-38,025
| -18% | -$1.28M |
|
2813
Under Armour Class C
UA
$2.53B
| $6.3M | ﹤0.01% |
423,275
-1,359,127
| -76% | -$18.2M |
|
2814
CALL
Carnival Corporation Ltd
CCL
$39.7B
| $6.29M | ﹤0.01% |
290,200
-188,700
| -39% | -$3.36M |
|
2815
CALL
US Global Jets ETF
JETS
$800M
| $6.28M | ﹤0.01% |
+280,600
| New | +$5.65M |
|
|
SJI
2816
DELISTED
South Jersey Industries, Inc.
SJI
| $6.27M | ﹤0.01% |
291,033
-143,007
| -33% | -$3.09M |
|
2817
GFL Environmental
GFL
$14.9B
| $6.27M | ﹤0.01% |
214,861
+114,770
| +115% | +$2.81M |
|
2818
PUT
Moderna
MRNA
$23.6B
| $6.27M | ﹤0.01% |
60,000
-23,600
| -28% | -$2.39M |
|
2819
CALL
S&P Global
SPGI
$120B
| $6.25M | ﹤0.01% |
19,000
-5,000
| -21% | -$1.69M |
|
2820
Telus
TU
$15.3B
| $6.23M | ﹤0.01% |
314,427
-203,230
| -39% | -$3.83M |
|
2821
CALL
ARK Innovation ETF
ARKK
$6.31B
| $6.22M | ﹤0.01% |
+50,000
| New | +$5.42M |
|
|
LOKB.U
2822
DELISTED
Live Oak Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-th
LOKB.U
| $6.21M | ﹤0.01% |
+572,520
| New | +$5.99M |
|
2823
Theravance Biopharma
TBPH
$877M
| $6.21M | ﹤0.01% |
349,509
+34,344
| +11% | +$617K |
|
2824
United States Natural Gas Fund
UNG
$455M
| $6.21M | ﹤0.01% |
168,754
| – | – |
|
2825
PUT
AB InBev
BUD
$165B
| $6.2M | ﹤0.01% |
88,700
| – | – |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.